WAC 246-650-050
Privacy and security of screening
specimen/information forms. The specimen/information form
submitted to the department pursuant to WAC 246-650-020
becomes the property of the state of Washington upon receipt
by the Washington state public health laboratory. The
department shall protect the privacy of newborns and their
families and assure that all specimen/information forms
submitted for screening are protected from inappropriate use
or access.
(1) Storage: The specimen/information forms shall be
kept at ambient temperature in secured storage to preserve
their confidentiality and prevent access by unauthorized
persons.
(2) Retention/destruction: The specimen/information form
shall be retained until the child is twenty-one years old in
accordance with the requirements for hospitals specified in
RCW 70.41.190. After this time the form will be destroyed.
EXCEPTION FOR PARENTAL REQUEST: Upon request of a parent or
guardian (or a patient who is over the age of eighteen years),
the department will destroy the specimen/information form only
after all required screening tests have been performed and if
the patient's screening/clinical status related to these tests
is not in question.
(3) Access: Access to stored specimen/information forms
shall be restricted to department employees and those
contractors or others approved by the department as necessary
to meet specific program needs. Access is contingent upon
compliance with all applicable federal and state laws,
regulations, and policies safeguarding the privacy and
confidentiality of medical information. The department shall
assure that those granted access understand the
confidentiality requirements and have a signed confidentiality
agreement on file.
(4) Release: Dried blood spot samples and specimen
information may only be released when required by state or
federal law or under the following conditions:
(a) A sample from a specimen and copies of associated
information (patient information and testing results, if
requested) may be released to:
(i) A health care provider at the request of the patient
or their legal representative after completing and signing a
written request form approved by the department. The release
form must be provided to the director of newborn screening
before the request will be fulfilled.
(ii) A researcher with the written, informed consent of
the patient or their patient's legal representative as part of
a research project that has been reviewed and approved by the
DOH/DSHS human subjects research review board and the
secretary or designee of the department of health.
(iii) A named person in a legally executed subpoena
following review and approval of the state attorney general.
(iv) A person to whom release is mandated by order of a
court of competent jurisdiction.
(b) Anonymous samples may be released if the department
determines that the intended use has significant potential
health benefit and that each of the following criteria have
been met:
(i) The investigation design is adequate to assure
anonymity will be preserved.
(ii) All newborn screening tests have been completed and
the status of the infant is resolved.
(iii) At least one fully adequate spot will remain after
the anonymous sample has been taken.
(iv) Sufficient resources (personnel) are available for
extracting the samples.
(v) The DOH/DSHS human subjects research review board has
reviewed and approved the investigation. This requirement may
be waived by the department for a very small (i.e., less than
100 sample) pilot study where the intent is to evaluate a
testing tool, as opposed to an evaluation where the intent is
to measure some characteristic of a population.
(5) Notification: The department shall notify parents of
the specimen storage, retention/destruction and access
requirements through the department's newborn screening
informational pamphlet.
[Statutory Authority: Chapters 70.83, 43.20 RCW. 03-24-026,
§ 246-650-050, filed 11/24/03, effective 12/25/03.]